Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × apremilast × Clear all

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Psoriasis 1 Pruritus 1 Lymphoma, Follicular 1

Interventions

Cyclophosphamide 2784 Cisplatin 2762 Carboplatin 2562 Radiotherapy 2363 Paclitaxel 2349 Gemcitabine 2213 pembrolizumab 2034 Docetaxel 1919 Bevacizumab 1871 Fluorouracil 1614 Capecitabine 1581 Oxaliplatin 1502 Dexamethasone 1388 Nivolumab 1316 Doxorubicin 1303 Rituximab 1288 Etoposide 1185 Magnetic Resonance Spectroscopy 1105 Irinotecan 1092 Leucovorin 1072 Cytarabine 997 Drug Therapy 931 fludarabine 920 Pemetrexed 917 Vincristine 830 Prednisone 820 Lenalidomide 813 Cetuximab 799 Specimen Handling 798 Filgrastim 793

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03721172 2024-05-29

ADVANCE

Amgen

Phase 3 Completed

595 enrolled 19 charts

Lymphoma, Follicular, Pruritus, Psoriasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡